Comparable adjusted operating profit was MEUR Comparable adjusted profit was MEUR Comparable adjusted diluted earnings per share were The complete report is available in pdf-format as an attachment to this release and on the company's website at https: Especially our Investment business had a positive impact on our results; we saw a successful exit from Idean in the first quarter and an increase in the fair values of CapMan's own fund investments and Astra zeneca forlorare pa borsen portfolio.
Other business areas also developed favourably. The ongoing development work in our Buyout portfolio companies is now reflected as positive value We are also actively looking for new exit opportunities in the prevailing favourable capital market environment.
Our various real estate transactions during the first half reflect the positive activity in the real estate market. In June, we made two new real estate investments in the Nordics of which the mixed-used commercial property St. Olavs Gate was our first property investment in Norway.
An important factor in CapMan's growth strategy is our Services business, which had an excellent performance in the first half of Furthermore, Scala Fund Advisory, which offers specialised private equity fund raising and advisory services, completed several mandates during the review period; a fund raising for one of the largest US private markets asset management firm Hamilton Lane mandate, among others.
In addition to this, the demand both in the Nordics and internationally for Scala's services has been strong and several mandates will be executed during One of the key themes in is growing the revenues of our Management Company and Services business.
For this part, our growth iniatives are starting to materialize. The fund raising of CapMan Nordic Real Estate II fund will be completed during the third quarter and we are also planning to launch other new Real Estate investment products.
We are planning to establish a Growth Equity fund and we have strengthened the Growth Equity team with a new recruitment, as announced earlier today. The activity of CapMan Infra, focusing on Nordic mid-cap infrastructure assets, has gotten off to a good start and we have already gathered a number of deal opportunities, which we will develop further in Looking to the future, I see that we are in a good position for profitable growth due to our diverse business portfolio, which is developing favourably.
We will continue the systematic development work of our business areas and launch new investment products. We are developing CapMan forward a leading private equity investment and asset management company in the Nordics. I would like extend a warm thank you for our investors, shareholders and CapMan's personnel for
Astra zeneca forlorare pa borsen successful first half.
We have a good basis to continue the strong development during the year CapMan renewed its financial objectives at the "Astra zeneca forlorare pa borsen" of The growth objective for Management Company and Services business is more than 10 per cent p.
The objective for return on equity is more than 20 per cent p. The objective for net gearing, that is ratio of net interest bearing debt to equity, is a maximum of 40 per cent on average. CapMan's objective is to pay at least 75 per cent of earnings per share as dividend. expects to achieve these financial objectives gradually and key figures are expected to show seasonality. CapMan expects fees from services to have a larger impact on results from the Management Company and Services business in The Management Company and Services business is profitable before carried interest income and any possible items affecting comparability.
The integration of Norvestia and other growth initiatives will generate expenses in The return on CapMan's investments have a substantial impact on CapMan's overall result. The development of Astra zeneca forlorare pa borsen and local economies, inflation development, valuation multiples of peer companies, exchange rates and various other factors outside of CapMan's control influence fair value development of CapMan's overall investments in addition to company and real estate specific development.
CapMan's objective is to improve results longer term, taking into account the seasonality affecting services and the Investment business. For these and other above mentioned reasons, CapMan does not provide numeric estimates for CapMan uses alternative performance measures to denote the financial performance of its business and to improve the comparability between different periods.
Alternative performance measures do not replace performance measures in accordance with the IFRS and are reported in addition to such measures.
Alternative performance measures, as such are presented, are derived from performance measures as reported in accordance with the IFRS by adding or deducting the items affecting comparability and they will be nominated as adjusted.
Items affecting comparability are, among others, material items related to mergers and acquisitions or major development projects, material gains or losses related to the acquisition or disposals of business units, material gains or losses related to the acquisition or disposal of intangible assets, material expenses related to decisions by authorities and material gains or losses related to reassessment of potential "Astra zeneca forlorare pa borsen" risk to the funds.
CapMan's management will present the result for the review period to press, analysts and investors and review the market situation in a press conference to be held at The press and analyst conference will be held in Finnish. To join the conference, please register with katariina. As one of the Nordic private equity pioneers we have actively developed hundreds of companies and real estate and thereby created substantial value in these businesses and assets over the last 25 years.
We mainly manage the assets of our customers, the investors, but also make direct investments from our own balance sheet in areas without an active fund. Our objective is to provide attractive returns and innovative solutions to investors and value adding services to professional investment partnerships, growth-oriented companies and tenants. We also have a growing service business that currently includes fundraising advisory, procurement activities and fund management.
Items affecting comparability and alternative performance measures CapMan uses alternative performance measures to denote the financial performance of its business Astra zeneca forlorare pa borsen to improve the comparability between different periods. EEST CapMan's management will present the result for the review period to press, analysts and investors and review the market situation in a press conference to be held at Haavisto, CFO, tel.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein. CapMan Oyj via Globenewswire. Items related to the acquisition of Norvestia, of which:.
Stockholmsbörsen steg, liksom övriga europeiska börser, på lättnad kring ett I London steg börsen med 0,6 procent där FTSE nådde nytt "all Även en av årets förlorare, medicinteknikbolaget Getinge, fanns bland vinnarna. Astra Zeneca steg med 1,6 procent efter godkännande för Lokelma i USA.
//profilo-servis.info innovationslaboratorium profilo-servis.info -s-imfinzi--durvalumab-- -s-resebarometerturkiet-och-usa-forlorare-- grekland-och-norge-vin .com/se/invuo-technologies-ab/r/seamless-tar- dotterbolaget-sds-till-borsen. Bank of Japan oförändrad policy, depositränta kvar på procent. 31 oktober BÖRSEN: VERKSTAD OCH RÅVAROR LYFTER, OMXS30 +0,6%.